Related Experiment Video
Updated: May 17, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Central serous chorioretinopathy due to tadalafil use
Fatih Mehmet Türkcü1, Harun Yüksel, Alparslan Şahin
1Department of Ophthalmology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey. turkcufm@gmail.com
Abstract:
Phosphodiesterase-5 (PDE5) inhibitors are commonly used in the treatment of erectile dysfunction. There are a small number of case reports that associate this agent with central serous chorioretinopathy (CSCR). Our report presents the treatment approach to a 42-year-old patient who described blurred vision and metamorphopsia and was diagnosed with CSCR following the use of tadalafil, a PDE5 inhibitor.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
Photoreceptors and Visual Pathways